BHC
Price
$7.44
Change
-$0.21 (-2.75%)
Updated
Jan 17 closing price
Capitalization
3.86B
32 days until earnings call
VTRS
Price
$11.30
Change
-$0.04 (-0.35%)
Updated
Jan 17 closing price
Capitalization
14.18B
44 days until earnings call
Ad is loading...

BHC vs VTRS

Header iconBHC vs VTRS Comparison
Open Charts BHC vs VTRSBanner chart's image
Bausch Health Companies
Price$7.44
Change-$0.21 (-2.75%)
Volume$3.77M
Capitalization3.86B
Viatris
Price$11.30
Change-$0.04 (-0.35%)
Volume$7.72M
Capitalization14.18B
BHC vs VTRS Comparison Chart
Loading...
BHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BHC vs. VTRS commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BHC is a Hold and VTRS is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (BHC: $7.44 vs. VTRS: $11.30)
Brand notoriety: BHC: Notable vs. VTRS: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BHC: 268% vs. VTRS: 87%
Market capitalization -- BHC: $3.86B vs. VTRS: $14.18B
BHC [@Pharmaceuticals: Other] is valued at $3.86B. VTRS’s [@Pharmaceuticals: Other] market capitalization is $14.18B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.54B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BHC’s FA Score shows that 0 FA rating(s) are green whileVTRS’s FA Score has 2 green FA rating(s).

  • BHC’s FA Score: 0 green, 5 red.
  • VTRS’s FA Score: 2 green, 3 red.
According to our system of comparison, VTRS is a better buy in the long-term than BHC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BHC’s TA Score shows that 3 TA indicator(s) are bullish while VTRS’s TA Score has 3 bullish TA indicator(s).

  • BHC’s TA Score: 3 bullish, 4 bearish.
  • VTRS’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, BHC is a better buy in the short-term than VTRS.

Price Growth

BHC (@Pharmaceuticals: Other) experienced а -5.58% price change this week, while VTRS (@Pharmaceuticals: Other) price change was -3.17% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.23%. For the same industry, the average monthly price growth was +2.88%, and the average quarterly price growth was -9.56%.

Reported Earning Dates

BHC is expected to report earnings on May 07, 2025.

VTRS is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.23% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTRS($14.2B) has a higher market cap than BHC($3.86B). VTRS has higher P/E ratio than BHC: VTRS (238.80) vs BHC (13.39). BHC YTD gains are higher at: -7.692 vs. VTRS (-9.237). VTRS has higher annual earnings (EBITDA): 3.52B vs. BHC (2.2B). VTRS has more cash in the bank: 1.18B vs. BHC (947M). VTRS has less debt than BHC: VTRS (18.4B) vs BHC (22.4B). VTRS has higher revenues than BHC: VTRS (15.4B) vs BHC (8.76B).
BHCVTRSBHC / VTRS
Capitalization3.86B14.2B27%
EBITDA2.2B3.52B63%
Gain YTD-7.692-9.23783%
P/E Ratio13.39238.806%
Revenue8.76B15.4B57%
Total Cash947M1.18B80%
Total Debt22.4B18.4B122%
FUNDAMENTALS RATINGS
BHC vs VTRS: Fundamental Ratings
BHC
VTRS
OUTLOOK RATING
1..100
2058
VALUATION
overvalued / fair valued / undervalued
1..100
35
Fair valued
20
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10091
PRICE GROWTH RATING
1..100
5759
P/E GROWTH RATING
1..100
981
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTRS's Valuation (20) in the null industry is in the same range as BHC (35) in the Pharmaceuticals Other industry. This means that VTRS’s stock grew similarly to BHC’s over the last 12 months.

VTRS's Profit vs Risk Rating (100) in the null industry is in the same range as BHC (100) in the Pharmaceuticals Other industry. This means that VTRS’s stock grew similarly to BHC’s over the last 12 months.

VTRS's SMR Rating (91) in the null industry is in the same range as BHC (100) in the Pharmaceuticals Other industry. This means that VTRS’s stock grew similarly to BHC’s over the last 12 months.

BHC's Price Growth Rating (57) in the Pharmaceuticals Other industry is in the same range as VTRS (59) in the null industry. This means that BHC’s stock grew similarly to VTRS’s over the last 12 months.

VTRS's P/E Growth Rating (1) in the null industry is significantly better than the same rating for BHC (98) in the Pharmaceuticals Other industry. This means that VTRS’s stock grew significantly faster than BHC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BHCVTRS
RSI
ODDS (%)
N/A
Bullish Trend 5 days ago
72%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 5 days ago
65%
Momentum
ODDS (%)
Bearish Trend 5 days ago
80%
Bearish Trend 5 days ago
69%
MACD
ODDS (%)
Bullish Trend 5 days ago
78%
N/A
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
79%
Bearish Trend 5 days ago
63%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
77%
Bearish Trend 5 days ago
61%
Advances
ODDS (%)
Bullish Trend 19 days ago
74%
N/A
Declines
ODDS (%)
Bearish Trend 16 days ago
78%
Bearish Trend 9 days ago
65%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
89%
Bullish Trend 5 days ago
61%
Aroon
ODDS (%)
Bearish Trend 5 days ago
76%
Bearish Trend 5 days ago
66%
View a ticker or compare two or three
Ad is loading...
BHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X104462.0400004705.133000
+4.72%
Bitcoin cryptocurrency
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
GME27.51-0.21
-0.76%
GameStop Corp

BHC and

Correlation & Price change

A.I.dvisor tells us that BHC and PRFX have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BHC and PRFX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BHC
1D Price
Change %
BHC100%
-2.75%
PRFX - BHC
27%
Poorly correlated
-7.08%
PAHC - BHC
26%
Poorly correlated
-0.53%
HLN - BHC
26%
Poorly correlated
+0.54%
SWDCF - BHC
25%
Poorly correlated
N/A
VTRS - BHC
25%
Poorly correlated
-0.35%
More

VTRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTRS has been loosely correlated with ALKS. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if VTRS jumps, then ALKS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTRS
1D Price
Change %
VTRS100%
-0.35%
ALKS - VTRS
34%
Loosely correlated
-0.94%
PRGO - VTRS
33%
Poorly correlated
-0.08%
PBH - VTRS
27%
Poorly correlated
+0.38%
DVAX - VTRS
26%
Poorly correlated
+0.48%
TEVA - VTRS
26%
Poorly correlated
+1.11%
More